Shmulik Hess
Director de Operaciones en MEDIWOUND LTD. .
Perfil
Dr. Shmulik Hess is a Chief Operating & Commercial Officer at MediWound Ltd.
Dr. Hess was previously employed as a Chief Executive Officer by Valin Technologies Ltd., a Global Operations by SciGen Ltd., a Chief Executive Officer by Active PX Ltd., a Chief Executive Officer by Enlivex Therapeutics Ltd., and a Chief Executive Officer by Tabby Therapeutics Ltd.
He received his doctorate degree from The Hebrew University of Jerusalem.
Cargos activos de Shmulik Hess
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDIWOUND LTD. | Director de Operaciones | 01/12/2023 |
Antiguos cargos conocidos de Shmulik Hess.
| Empresas | Cargo | Fin |
|---|---|---|
| Valin Technologies Ltd. | Director Ejecutivo | 01/11/2018 |
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Director Ejecutivo | 01/09/2011 |
| SCIGEN LIMITED | Director de Operaciones | 01/03/2010 |
| ENLIVEX THERAPEUTICS LTD. | Director Ejecutivo | - |
Tabby Therapeutics Ltd.
 Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Director Ejecutivo | - |
Formación de Shmulik Hess.
| The Hebrew University of Jerusalem | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MEDIWOUND LTD. | Health Technology |
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Empresas privadas | 4 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
| Valin Technologies Ltd. | |
Tabby Therapeutics Ltd.
Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Health Technology |
- Bolsa de valores
- Insiders
- Shmulik Hess
